Several specialized companies worldwide focus on the production of complex drug APIs, notably Abacavir sulfate, Abarelix, and Abiraterone Acetate. These molecules present significant hurdles in synthetic building due to their molecular sophistication. The suppliers of these APIs often employ advanced technologies and adhere to strict regulatory pro